Form 4: Celestica Director Reports Routine Equity Transactions
Insider Transaction Report
Celestica Director Michael Max Wilson reported the vesting of restricted share units and acquisition of director share units, alongside a sale of shares to cover tax obligations.
Summary
- Director Michael Max Wilson reported transactions on September 30, 2025, including the acquisition and disposition of common shares and derivative securities.
- Acquired 5,657 common shares through the exercise/conversion of derivative securities.
- Disposed of 2,718 common shares at a price of $246.38 per share to satisfy tax withholding obligations arising from the vesting of restricted share units (RSUs).
- Vested 3,640 Restricted Share Units (RSUs) from a grant made on September 30, 2022.
- Vested 1,348 Restricted Share Units (RSUs) from a grant made on September 30, 2023.
- Vested 669 Restricted Share Units (RSUs) from a grant made on September 30, 2024.
- Acquired 416 Director Share Units (DSUs).
- Following these transactions, Michael Max Wilson directly beneficially owns 16,330 common shares, 1,347 RSUs (from the 2023 grant), 1,337 RSUs (from the 2024 grant), and 1,087 DSUs.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions related to equity compensation, including RSU vesting and a subsequent share sale for tax purposes. These are standard compensation events and do not indicate a significant positive or negative shift in company fundamentals or insider sentiment.
Positives
- Director Michael Max Wilson received 5,657 common shares through the vesting of equity awards, indicating ongoing compensation and alignment with shareholder interests.
- The acquisition of 416 Director Share Units (DSUs) further increases the director's equity-based compensation.
Negatives
- Director Michael Max Wilson disposed of 2,718 common shares, valued at $246.38 per share, to cover tax withholding obligations, resulting in a reduction of direct common share ownership.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minor dilution from RSU vesting, but also alignment of the director's interests with company performance through equity compensation.
Next Steps
- Annual vesting of remaining Restricted Share Units (RSUs) granted on September 30, 2023, over 3 years.
- Annual vesting of remaining Restricted Share Units (RSUs) granted on September 30, 2024, over 3 years.
Key Dates
| Date | Description |
|---|---|
| 09/30/2022 | Grant date for 10,920 Restricted Share Units (RSUs) to Michael Max Wilson. |
| 09/30/2023 | Grant date for 4,042 Restricted Share Units (RSUs) to Michael Max Wilson. |
| 09/30/2024 | Grant date for 2,006 Restricted Share Units (RSUs) to Michael Max Wilson. |
| 09/30/2025 | Date of reported transactions, including RSU vesting, common share acquisition and disposition, and DSU acquisition. |
| 10/01/2025 | Signature date for the Form 4 filing. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to director compensation, specifically the vesting of restricted share units and a subsequent sale of shares to cover tax obligations. Such transactions are expected as part of an executive's compensation package and do not provide new fundamental information about the company's operational performance or strategic direction. Therefore, it does not warrant a change in investment recommendation.
Keywords
Celestica, CLS, Form 4, insider transaction, director compensation, RSU vesting, equity awards, share units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.